Abingdon Health Plc (ABDX) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.204x

Based on the latest financial reports, Abingdon Health Plc (ABDX) has a cash flow conversion efficiency ratio of -0.204x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.28 Million ≈ $-156.10 USD) by net assets (GBX6.30 Million ≈ $766.65 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Abingdon Health Plc (ABDX) net asset quality to measure how much of total assets are equity-financed.

Abingdon Health Plc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Abingdon Health Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Abingdon Health Plc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Abingdon Health Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Abingdon Health Plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mitra Komunikasi Nusantara Tbk PT JK:MKNT	-0.463x
Sanco Industries Limited NSE:SANCO	0.025x
Dewhurst plc LSE:DWHA	0.062x
Cordel Group PLC LSE:CRDL	-0.209x
Subsea 7 SA LSE:0OGK	-0.030x
Kavango Resources PLC LSE:KAV	-0.160x
Desarrolladora Homex S.A.B. de C.V MX:HOMEX	-0.024x
GO.D.M Investments Ltd TA:GODM	-0.255x

Annual Cash Flow Conversion Efficiency for Abingdon Health Plc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Abingdon Health Plc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Abingdon Health Plc (ABDX) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX5.30 Million ≈ $644.86	GBX-3.18 Million ≈ $-387.16	-0.600x	+18.61%
2024-06-30	GBX2.25 Million ≈ $273.64	GBX-1.66 Million ≈ $-201.85	-0.738x	-321.52%
2023-06-30	GBX3.01 Million ≈ $366.11	GBX1.00 Million ≈ $121.91	0.333x	+127.69%
2022-06-30	GBX6.43 Million ≈ $782.59	GBX-7.74 Million ≈ $-941.13	-1.203x	-99.19%
2021-06-30	GBX21.33 Million ≈ $2.59K	GBX-12.88 Million ≈ $-1.57K	-0.604x	-179.22%
2020-06-30	GBX2.75 Million ≈ $334.47	GBX2.10 Million ≈ $254.90	0.762x	+610.73%
2019-06-30	GBX6.09 Million ≈ $740.58	GBX-908.25K ≈ $-110.51	-0.149x	+65.99%
2018-06-30	GBX5.81 Million ≈ $707.29	GBX-2.55 Million ≈ $-310.29	-0.439x	-103.06%
2016-12-31	GBX-115.66K ≈ $-14.07	GBX-1.66 Million ≈ $-201.83	14.342x	--

About Abingdon Health Plc

LSE:ABDX UK Diagnostics & Research

Market Cap

$320.76K

GBX2.64 Billion GBX

Market Cap Rank

#31063 Global

#973 in UK

Share Price

GBX10.50

Change (1 day)

+0.00%

52-Week Range

GBX5.25 - GBX12.75

All Time High

GBX125.63